5BQ0

Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R)-3-(4-tert-bu tylbenzamido)piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) phenyl]amino}pyridine-3-carboxamide

Summary for 5BQ0

• Entry DOI: 10.2210/pdb5bq0/pdb
• Related: 5BPY
• Descriptor: Tyrosine-protein kinase BTK, 4-(2-chlorophenyl)-7-[(4-methylpiperazin-1-yl)carbonyl]-9H-carbazole-1-carboxamide, DIMETHYL SULFOXIDE, ... (5 entities in total)
• Functional Keywords: kinase, inhibitor, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• Biological source: Homo sapiens (Human)
• Cellular location: Cytoplasm: Q06187
• Total number of polymer chains: 1
• Total formula weight: 33329.67

Authors

Muckelbauer, J.K. (deposition date: 2015-05-28, release date: 2015-09-23, Last modification date: 2024-03-06)

Primary citation

Liu, Q.,Batt, D.G.,Lippy, J.S.,Surti, N.,Tebben, A.J.,Muckelbauer, J.K.,Chen, L.,An, Y.,Chang, C.,Pokross, M.,Yang, Z.,Wang, H.,Burke, J.R.,Carter, P.H.,Tino, J.A.
Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 2 (JAK2).
Bioorg.Med.Chem.Lett., 25:4265-4269, 2015

PubMed Abstract: Four series of disubstituted carbazole-1-carboxamides were designed and synthesised as inhibitors of Bruton's tyrosine kinase (BTK). 4,7- and 4,6-disubstituted carbazole-1-carboxamides were potent and selective inhibitors of BTK, while 3,7- and 3,6-disubstituted carbazole-1-carboxamides were potent and selective inhibitors of Janus kinase 2 (JAK2).

PubMed: 26320619
DOI: 10.1016/j.bmcl.2015.07.102

Experimental method

X-RAY DIFFRACTION (1.57 Å)